Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma

被引:3
|
作者
Wang, Huimin [1 ,2 ,3 ,4 ,5 ]
Yang, Xiaoang [1 ]
Sun, Guiying [3 ,4 ,5 ]
Yang, Qian [3 ,4 ,5 ]
Cui, Chi [1 ,3 ,4 ]
Wang, Xiao [1 ,3 ,4 ]
Ye, Hua [3 ,4 ,5 ]
Dai, Liping [1 ,3 ,4 ]
Shi, Jianxiang [1 ,3 ,4 ]
Zhang, Jianying [1 ,3 ,4 ]
Wang, Peng [1 ,3 ,4 ,5 ]
机构
[1] Zhengzhou Univ, Acad Med Sci, Henan Inst Med & Pharmaceut Sci, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Sch Basic Med Sci, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Henan Key Lab Tumor Epidemiol, Zhengzhou, Peoples R China
[4] Zhengzhou Univ, State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou, Peoples R China
[5] Zhengzhou Univ, Coll Publ Hlth, Zhengzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
GNA11; tumor-associated antigen; autoantibody; immunodiagnosis; esophageal squamous cell carcinoma; DIAGNOSTIC BIOMARKER; CANCER; EXPRESSION; REPORTERS;
D O I
10.3389/fonc.2021.661043
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The study aims to explore the diagnostic value of anti-GNA11 autoantibody in esophageal squamous cell carcinoma (ESCC) from multiple levels. Autoantibody against GNA11 with the highest diagnostic performance was screened out from the customized protein microarray. A total of 486 subjects including ESCC patients and matched normal controls were recruited in the verification and validation phases by using enzyme-linked immunosorbent assay (ELISA). Western blotting analysis was used to verify the ELISA results. Immunohistochemistry (IHC) was used to evaluate GNA11 expression in ESCC tissues and para-tumor tissues. In addition, a bioinformatics approach was adopted to investigate the mRNA expression of GNA11 in ESCC. Results indicated that the level of anti-GNA11 autoantibody in ESCC patients was significantly higher than that in the normal controls, and it can be used to distinguish ESCC patients from normal individuals in clinical subgroups (p < 0.05), as revealed by both ELISA and Western blotting. The receiver operating characteristic (ROC) curve analysis showed that anti-GNA11 autoantibody could distinguish ESCC patients from normal controls with an area under the ROC curve (AUC) of 0.653, sensitivity of 10.96%, and specificity of 98.63% in the verification cohort and with an AUC of 0.751, sensitivity of 38.24%, and specificity of 88.82% in the validation cohort. IHC manifested that the expression of GNA11 can differentiate ESCC tissues with para-tumor tissues (p < 0.05), but it cannot be used to differentiate different pathological grades and clinical stages (p > 0.05). The mRNA expression of GNA11 in ESCC patients and normal controls was different with a bioinformatics mining with The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) data in Gene Expression Profiling Interactive Analysis (GEPIA). In summary, anti-GNA11 autoantibody has the potential to be a new serological marker in the diagnosis of ESCC.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Tumor-associated antigen expression and growth requirements predict tumorigenesis in squamous cell carcinoma
    Sauter, ER
    Tichansky, D
    Furth, EE
    Herlyn, M
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2001, 37 (08) : 530 - 535
  • [22] Tumor-associated antigen expression and growth requirements predict tumorigenesis in squamous cell carcinoma
    Sauter E.R.
    Tichansky D.
    Furth E.E.
    Herlyn M.
    In Vitro Cellular & Developmental Biology - Animal, 2001, 37 (8) : 530 - 535
  • [23] Identification of genes associated with histologic tumor grade of esophageal squamous cell carcinoma
    Xing, Jiaqiang
    Liu, Cuicui
    FEBS OPEN BIO, 2017, 7 (09): : 1246 - 1257
  • [24] Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma
    Chen Wang
    Guiying Sun
    Huimin Wang
    Liping Dai
    Jianying Zhang
    Renle Du
    BMC Cancer, 22
  • [25] Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma
    Wang, Chen
    Sun, Guiying
    Wang, Huimin
    Dai, Liping
    Zhang, Jianying
    Du, Renle
    BMC CANCER, 2022, 22 (01) : 932
  • [26] Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
    Sun, Guiying
    Ye, Hua
    Wang, Xiao
    Li, Tiandong
    Jiang, Di
    Qiu, Cuipeng
    Dai, Liping
    Shi, Jianxiang
    Wang, Kaijuan
    Song, Chunhua
    Wang, Peng
    Zhang, Jianying
    CANCER MEDICINE, 2020, 9 (03): : 1173 - 1182
  • [27] Identification of tumor-associated proteins in well differentiated laryngeal squamous cell carcinoma by proteomics
    Zhou J.-R.
    Fu Z.-X.
    Li J.
    Wei L.-Z.
    Li J.-C.
    Clinical Proteomics, 2007, 3 (1-4) : 42 - 47
  • [28] Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC)
    Dong, Yan
    Xue, Liyan
    Zhang, Yan
    Liu, Caiyun
    Zhang, Yanguang
    Jiang, Na
    Ma, Xiaoyan
    Chen, Fangyu
    Li, Lingxia
    Yu, Liyuan
    Liu, Xuefeng
    Shao, Shujuan
    Guan, Shufang
    Zhang, Jian
    Xiao, Qingchun
    Li, Hui
    Dong, Ailing
    Huang, Lijie
    Shi, Chenyang
    Wang, Yan
    Fu, Ming
    Lv, Ning
    Zhan, Qimin
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [29] Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC)
    Yan Dong
    Liyan Xue
    Yan Zhang
    Caiyun Liu
    Yanguang Zhang
    Na Jiang
    Xiaoyan Ma
    Fangyu Chen
    Lingxia Li
    Liyuan Yu
    Xuefeng Liu
    Shujuan Shao
    Shufang Guan
    Jian Zhang
    Qingchun Xiao
    Hui Li
    Ailing Dong
    Lijie Huang
    Chenyang Shi
    Yan Wang
    Ming Fu
    Ning Lv
    Qimin Zhan
    Journal of Experimental & Clinical Cancer Research, 41
  • [30] Apoptotic function of tumor-associated antigen RCAS1 in oral squamous cell carcinoma
    Hideaki Tanaka
    Takeshi Toyoshima
    Kenzo Sonoda
    Ryoji Kitamura
    Masaaki Sasaguri
    Shintaro Kawano
    Ryota Matsubara
    Yuichi Goto
    Seiji Nakamura
    Journal of Translational Medicine, 12